Debra Werner, MD
Gynecology · Staten Island, NYNPI 1760577258
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,326 of the $5,997 with a category attached, or 88.8%. 27 manufacturers reported payments, led by Exeltis, USA Inc. at 31.8% of the total. Reporting peaked in 2019 at $1,437 and has fallen 57.1% since, to $617 in 2025.
Across 305 payments — averaging $19.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exeltis, USA Inc.$2K
- AbbVie$1K
- Evofem Biosciences, Inc.$341
- Agile Therapeutics, Inc.$310
- Astellas Pharma US Inc$273
- Sumitomo Pharma America, Inc.$231
- plus $2K from 21 others
What the payments were for
- Consulting fees$5008%
- Food & beverage$5,32689%
- Education$1713%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exeltis, USA Inc. | 91 | $1,907 |
| AbbVie(2 entities) | 51 | $1,084 |
| Evofem Biosciences, Inc. | 19 | $341 |
| Agile Therapeutics, Inc. | 13 | $310 |
| Astellas Pharma US Inc | 10 | $273 |
| Sumitomo Pharma America, Inc. | 12 | $231 |
| Pfizer | 14 | $228 |
| Lupin Inc. | 18 | $222 |
| Scynexis, Inc. | 11 | $220 |
| Mayne Pharma Commercial LLC | 10 | $212 |
| Therapeuticsmd, Inc. | 8 | $148 |
| Avion Pharmaceuticals | 10 | $136 |
| Myovant Sciences Inc. | 6 | $105 |
| Millicent US Inc | 6 | $92 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $81 |
| Vertex | 3 | $69 |
| Coopersurgical, Inc. | 2 | $59 |
| Exact Sciences | 2 | $49 |
| Vertical Pharmaceuticals, LLC | 2 | $37 |
| Roche Diagnostics Corporation | 2 | $37 |
| Shield Therapeutics Inc | 2 | $37 |
| Organon | 3 | $35 |
| Mylan Pharmaceuticals Inc. | 1 | $20 |
| AMAG Pharmaceuticals, Inc. | 1 | $19 |
| Duchesnay USA Incorporated | 1 | $18 |
| Biogen | 1 | $17 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,997 in reported general payments places this provider in the 85th percentile of 240 gynecology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 40 | $2,780 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 39 | $765 |
| Terconazole | 21 | $599 |
| Metronidazole | 11 | $216 |
| Nystatin | 18 | $184 |
| Ciprofloxacin Hcl | 36 | $161 |
| Fluconazole | 33 | $98 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $85 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Staten Island
- Susan KhalilStaten Island$115K
- Arnold AdvinculaNew York$2.1M
- Stephen CohenSyracuse$204K
- Diane SutterKenmore$95K
- Tamara KolevNew York$91K
- Shane SoppSyracuse$84K
- Charles Ascher-WalshNew York$43K
- Paula CastanoNew York$31K
- David KurssWilliamsville$25K
- Navpriya OberoiFayetteville$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.